Related Experiment Video
Updated: Mar 8, 2026

Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging
Published on: October 16, 2017
Annular phased array transducer for preclinical testing of anti-cancer drug efficacy on small animals
Tamara Kujawska1, Wojciech Secomski1, Michał Byra1
1Department of Ultrasound, Institute of Fundamental Technological Research, Polish Academy of Sciences, Pawińskiego 5b, 02-106 Warsaw, Poland.
Abstract:
A technique using pulsed High Intensity Focused Ultrasound (HIFU) to destroy deep-seated solid tumors is a promising noninvasive therapeutic approach. A main purpose of this study was to design and test a HIFU transducer suitable for preclinical studies of efficacy of tested, anti-cancer drugs, activated by HIFU beams, in the treatment of a variety of solid tumors implanted to various organs of small animals at the depth of the order of 1-2cm under the skin. To allow focusing of the beam, generated by such transducer, within treated tissue at different depths, a spherical, 2-MHz, 29-mm diameter annular phased array transducer was designed and built. To prove its potential for preclinical studies on small animals, multiple thermal lesions were induced in a pork loin ex vivo by heating beams of the same: 6W, or 12W, or 18W acoustic power and 25mm, 30mm, and 35mm focal lengths. Time delay for each annulus was controlled electronically to provide beam focusing within tissue at the depths of 10mm, 15mm, and 20mm. The exposure time required to induce local necrosis was determined at different depths using thermocouples. Location and extent of thermal lesions determined from numerical simulations were compared with those measured using ultrasound and magnetic resonance imaging techniques and verified by a digital caliper after cutting the tested tissue samples. Quantitative analysis of the results showed that the location and extent of necrotic lesions on the magnetic resonance images are consistent with those predicted numerically and measured by caliper. The edges of lesions were clearly outlined although on ultrasound images they were fuzzy. This allows to conclude that the use of the transducer designed offers an effective noninvasive tool not only to induce local necrotic lesions within treated tissue without damaging the surrounding tissue structures but also to test various chemotherapeutics activated by the HIFU beams in preclinical studies on small animals.
Insights
This study developed a High Intensity Focused Ultrasound (HIFU) transducer for noninvasive tumor treatment in preclinical studies. The device accurately creates localized thermal lesions, enabling drug efficacy testing for solid tumors.
Area of Science:
- Biomedical Engineering
- Oncology
- Medical Imaging
Background:
- Pulsed High Intensity Focused Ultrasound (HIFU) offers a noninvasive therapeutic approach for deep-seated solid tumors.
- Preclinical studies require precise tools to evaluate anti-cancer drugs activated by HIFU beams.
Purpose of the Study:
- Design and test a HIFU transducer for preclinical evaluation of HIFU-activated anti-cancer drugs.
- Assess the transducer's capability to treat solid tumors in small animals at depths of 1-2cm.
Main Methods:
- A spherical, 2-MHz, 29-mm diameter annular phased array transducer was designed and constructed.
- Thermal lesions were induced in ex vivo pork loin using varying acoustic power and focal lengths.
- Electronic control of time delays enabled beam focusing at specific tissue depths (10-20mm).
- Lesion characteristics were analyzed using numerical simulations, ultrasound, MRI, and digital calipers.
Main Results:
- The HIFU transducer successfully induced localized thermal necrotic lesions.
- Magnetic resonance imaging (MRI) confirmed lesion locations and extents consistent with numerical predictions and caliper measurements.
- Lesion edges were clearly defined on MRI, while ultrasound imaging showed fuzzier boundaries.
Conclusions:
- The designed HIFU transducer is an effective noninvasive tool for inducing localized necrotic lesions.
- It facilitates preclinical studies of HIFU-activated chemotherapeutics in small animal models.
- The system allows precise lesion induction without damaging surrounding tissues.

